← All trials
NCT05014672
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2021
- Primary completion
- Sep 16, 2024
- Completion date
- Sep 15, 2025
- First posted
- Aug 20, 2021
- Last posted
- Nov 19, 2021
- Enrollment
- 318
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Genkyotex Innovation SASLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.